Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial

Livingstone, E.; Gogas, H.; Kandolf-Sekulovic, L.; Meier, F.; Eigentler, T. K.; Ziemer, M.; Terheyden, P. A. M.; Gesierich, A. H.; Herbst, R. A.; Kaehler, K. C.; Ziogas, D. C.; Mijuskovic, Z.; Garzarolli, M.; Garbe, C.; Roesch, A.; Ugurel, S.; Gutzmer, R.; Grob, J. J.; Kiecker, F.; Utikal, J.; Windemuth-Kieselbach, C.; Eckhardt, S.; Zimmer, L.; Schadendorf, D.

dc.contributor.author	Eigentler, Thomas
dc.contributor.author	Garbe, Claus
dc.date.accessioned	2024-01-08T08:26:31Z
dc.date.available	2024-01-08T08:26:31Z
dc.date.issued	2023
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/148904
dc.language.iso	en	de_DE
dc.publisher	Oxford : Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2023.112941	de_DE
dc.subject.ddc	610	de_DE
dc.title	Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230928000000_00093
utue.personen.roh	Livingstone, E.
utue.personen.roh	Gogas, H.
utue.personen.roh	Kandolf-Sekulovic, L.
utue.personen.roh	Meier, F.
utue.personen.roh	Eigentler, T. K.
utue.personen.roh	Ziemer, M.
utue.personen.roh	Terheyden, P. A. M.
utue.personen.roh	Gesierich, A. H.
utue.personen.roh	Herbst, R. A.
utue.personen.roh	Kaehler, K. C.
utue.personen.roh	Ziogas, D. C.
utue.personen.roh	Mijuskovic, Z.
utue.personen.roh	Garzarolli, M.
utue.personen.roh	Garbe, C.
utue.personen.roh	Roesch, A.
utue.personen.roh	Ugurel, S.
utue.personen.roh	Gutzmer, R.
utue.personen.roh	Grob, J. J.
utue.personen.roh	Kiecker, F.
utue.personen.roh	Utikal, J.
utue.personen.roh	Windemuth-Kieselbach, C.
utue.personen.roh	Eckhardt, S.
utue.personen.roh	Zimmer, L.
utue.personen.roh	Schadendorf, D.
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article 112941	de_DE
dcterms.isPartOf.ZS-Volume	190	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE